Healthcare - Biotechnology - NASDAQ - US
$ 0.151
-4.37 %
$ 5.95 M
Market Cap
-0.13
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
22.32%
Net Income
Estimate
22.17%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Viracta Therapeutics, Inc.
VIRX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart VIRX
EBIT FORECAST
EBIT Forecast Chart VIRX
NET INCOME FORECAST
Net Income Chart VIRX